The OPEN Foundation has published hundreds of blog posts since its inception in 2007, including interviews with many leading psychedelic experts. On this page, you can access our publications that address various interdisciplinary topics, substances, and therapies.
Set and setting are deemed essential in preparation and facilitating therapeutic outcome in the landscape of psychedelic-assisted therapy. But what about potential environmental influences from the past, a phenomenon also referred to as ‘imprinting’?
Presenting a comprehensive study comparing psychedelics, meditation, and hypnosis, shedding light on their therapeutic applications in treating psychiatric disorders. Gain insights into the mind’s enigmatic experiences and potential future breakthroughs.
On June 23rd, 2023, the FDA made history in the psychedelics space by presenting its first-ever recommendations and considerations for executing clinical trials involving psychedelic drugs. With the growing popularity and research in this field, it’s a significant step forward in governmental institutions recognizing the potential of these substances.
Last week, OPEN executive director Joost Breeksema and OPEN board members Michiel van Elk and Patricia Posters gave lectures during the second edition of the Summer School on Psychedelic Research in Groningen, which was co-organised the OPEN Foundation.
The chronicles of the psychedelic renaissance continue as Ernst Kuipers responds to a recent report regarding its potential therapeutic use. This article provides a brief recap of the past year and summarizes Kuipers’ response that could provide a glimpse of what the future of psychedelic-assisted therapy and research in the Netherlands is going to look like.
From April 20th to 22nd, 2023, Breaking Convention convened in Exeter, United Kingdom. A mix of psychonauts, researchers, and psychedelic curious gathered to discuss the latest research, showcase psychedelic art, and exchange views in this blossoming field.
The Dutch Government establishes a state commission to investigate the risks and benefits of MDMA, including its potential medical use. The commission will study the impact of MDMA on individuals, society, and public health. Additionally, the commission will examine the advantages and disadvantages of potential medical applications of MDMA.
Joost Breeksema, director of the OPEN Foundation, made an appearance on Tuesday’s episode of Dutch talkshow OP1. The conversation delved into the use of psychedelics in psychiatry. Retired professional cyclist Thomas Dekker explained how he used magic truffles to fight his depression after leaving the sport. Joost joined the table as an expert on therapeutic applications of psychedelics and a proponent of a programmatic research and implementation programme.
On March 19 and 20, 2023, the European College of Neuropsychopharmacology (ECNP) organised the New Frontiers Meeting on Psychedelics in Nice, France. Various researchers and clinicians joined this event to talk about the current state of psychedelic-assisted psychotherapy (PAT). Here are some of the most interesting developments in the field of psychedelic research.
Stay informed about the latest research, news, and updates by subscribing to the OPEN Minded Newsletter. Every two weeks, we'll send you informative and insightful content about exclusive events, opportunities, programmes, and free resources!
By clicking SUBSCRIBE, I confirm to receive emails from the OPEN Foundation and agree with its privacy policy.